Contrast agents for cardiovascular magnetic resonance imaging: Current status and future directions

Drugs in R and D

Volumn 3, Issue 5, 2002, Pages 285-302

  Schalla, Simon ^a   Higgins, Charles B ^a   Saeed, Maythem ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMI 277; CONTRAST MEDIUM; DYSPROSIUM PENTETATE BIS(METHYLAMIDE); FERRISTENE; FERUMOXSIL; GADOBENATE DIMEGLUMINE; GADOBENATE DIMEGLUMINE POLYLYSINE; GADOBUTROL; GADODIAMIDE; GADOFOSVESET; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE DERIVATIVE; GADOLINIUM PENTETATE DEXTRAN; GADOMER 17; GADOPHRIN; GADOTERIC ACID; GADOTERIDOL; GADOVERSETAMIDE; IRON OXIDE; MANGAFODIPIR; MESOPORPHYRIN; METALLOPORPHYRIN; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; MYOSIN ANTIBODY; P 760; PENTETATE TECHNETIUM TC 99M; SINIREM; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANATOMY; ANGIOGENESIS; ANGIOPLASTY; BLOOD FLOWMETRY; BLOOD VESSEL; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR SYSTEM; DIAGNOSTIC PROCEDURE; DRUG CLEARANCE; DRUG DIFFUSION; DRUG PROTEIN BINDING; DRUG RESEARCH; GENE TARGETING; HEART; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE NECROSIS; HEART PERFUSION; MONITORING; MYOCARDITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 0037626860     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200203050-00001     Document Type: Review

References (122)

1. Lopez A. Assessing the burden of mortality from cardiovascular disease. World Health Stat Q 1993; 46: 91-6
2. Murray C, Lopez A. Global comparative Assessments in the health sector. Geneva, Switzerland: World Health Organization, 1994: 1-196
3. Reeder SB, Du YP, Lima JA, Bluemke DA. Advanced cardiac MR imaging of ischemic heart disease. Radiographics 2001 Jul-Aug; 21 (4): 1047-1074
4. Kramer CM. Integrated approach to ischemic heart disease. The one-stop shop. Cardiol Clin 1998 May; 16 (2): 267-76
5. Runge VM. Trends in contrast media research. Invest Radiol 2001 Dec; 36 (12): 688-91
6. Yang X, Atalar E. Intravascular MR imaging-guided balloon angioplasty with an MR imaging guide wire: feasibility study in rabbits. Radiology 2000 Nov; 217 (2): 501-6
7. Kuehne T, Saeed M, Reddy G, et al. Sequential magnetic resonance monitoring of pulmonary flow with endovascular stents placed across the pulmonary valve in growing Swine. Circulation 2001 Nov 6; 104 (19): 2363-8
8. Yang X, Atalar E, Li D, et al. Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 2001 Oct 2; 104 (14): 1588-90
9. Buecker A, Neuerburg JM, Adam GB, et al. Real-time MR fluoroscopy for MR-guided iliac artery stent placement. J Magn Reson Imaging 2000 Oct; 12 (4): 616-22
10. Dion YM, Ben El Kadi H, Boudoux C, et al. Endovascular procedures under near-real-time magnetic resonance imaging guidance: an experimental feasibility study. J Vasc Surg 2000 Nov; 32 (5): 1006-14
11. Serfaty JM, Atalar E, Declerck J, et al. Real-time projection MR angiography: feasibility study. Radiology 2000 Oct; 217 (1): 290-5
12. Enochs WS, Weissleder R. Organ- and tissue-directed MRI contrast agents. In: Edelman RR, Hesselink JR, Zlatkin MB. Clinical magnetic resonance imaging. 2nd edition 1996. W.B. Saunders Co., Philadelphia; 192-220
13. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997 Dec; 32 (12): 780-96
14. Weinmann HJ, Brasch RC, Press WR, et al. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984 Mar; 142 (3): 619-24
15. Fritz-Hansen T, Rostrup E, Sondergaard L, et al. Capillary transfer constant of Gd-DTPA in the myocardium at rest and during vasodilation assessed by MRI. Magn Reson Med 1998 Dec; 40 (6): 922-9
16. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998 May; 207 (2): 529-38
17. Lauffer RB, Parmelee DJ, Ouellet HS, et al. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol 1996 Aug; 3 Suppl. 2: S356-8
18. Rohl L, Ostergaard L. Simonsen CZ, et al. NC100150-enhanced 3D-SPGR MR angiography of the common carotid artery in a pig vascular stenosis model. Quantification of stenosis and dose optimization. Acta Radiol 1999 May; 40 (3): 282-90
19. Saeed M, Wendland MF, Engelbrecht M, et al. Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities. Eur Radiol 1998; 8 (6): 1047-53
20. Verhoye M, van der Sanden BP, Rijken PF, et al. Assessment of the neovascular permeability in glioma xenografts by dynamic T (1) MRI with Gadomer-17. Magn Reson Med 2002 Feb; 47 (2): 305-13
21. Misselwitz B, Schmitt-Willich H, Ebert W, et al. Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent. MAGMA 2001 May; 12 (2-3): 128-34
22. Kroft LJ, de Roos A. Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging 1999 Sep; 10 (3): 395-403
23. Schmitz SA, Coupland SE, Gust R, et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol 2000 Aug; 35 (8): 460-71
24. Jerosch-Herold M, Wilke N, Wang Y, et al. Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group. Int J Card Imaging 1999 Dec; 15 (6): 453-64
25. Gerber BL, Bluemke DA, Chin BB, et al. Comparison between Gadomer - 17 and gadolinium-DTPA for the assessment of myocardial perfusion using first pass MRI in a swine model of single vessel coronary artery stenosis [abstract]. Radiology 2000; 217 (Suppl.): 130
26. Wolf GL, Baum L. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. Am J Roentgenol 1983 Jul; 141(1): 193-7
27. Bremerich J, Saeed M, Arheden H, et al. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model. Radiology 2000 Aug; 216 (2):524-30
28. Pomeroy OH, Wendland M, Wagner S, et al. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP. Invest Radiol 1989 Jul; 24 (7): 531-6
29. Saeed M, Wagner S, Wendland MF, et al. Occlusive and reperfused myocardial infarcts: differentiation with Mn- DPDP--enhanced MR imaging. Radiology 1989 Jul; 172 (1): 59-64
30. Wendland MF, Krombach GA, Higgins CB, et al. Contrast enhanced MRI of stunned myocardium using Mn-based MRI contrast media. Acad Radiol 2002; 9 (Suppl. 2): 341-2
31. Pislaru SV, Ni Y, Pislaru C, et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 1999 Feb 9; 99 (5): 690-6
32. Saeed M, Bremerich J, Wendland MF, et al. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 1999 Oct; 213 (1): 247-57
33. Lund GK, Higgins CB, Wendland MF, et al. Assessment of nicorandil therapy in ischemic myocardial injury by using contrast-enhanced and functional MR imaging. Radiology 2001 Dec; 221 (3): 676-82
34. Barkhausen J, Ebert W, Debatin JF, et al. Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits. J Am Coll Cardiol 2002 Apr 17; 39 (8): 1392-8
35. Saeed M, Lee R, Martin A, et al. Feasibilty of transcatheter delivery of therapeutics to the myocardium using dual x-ray-MR imaging [abstract]. Honolulu: ISMRM, 2002: 340
36. Weissleder R, Lee AS, Khaw BA, et al. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 1992 Feb; 182 (2): 381-5
37. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001 Sep 11; 104 (11): 1280-5
38. Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001 Jan 23; 103 (3): 415-22
39. Crouse III JR. Predictive value of carotid 2-dimensional ultrasound. Am J Cardiol 2001 Jul 19; 88 (2-A): E27-30
40. Sun K, Takasu J, Yamamoto R, et al. Assessment of aortic atherosclerosis and carotid atherosclerosis in coronary artery disease. Jpn Circ J 2000 Oct; 64 (10): 745-9
41. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002 Jan 16; 39 (2): 225-30
42. Newman AB, Naydeck BL, Sutton-Tyrrell K, et al. Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation 2001 Nov 27; 104 (22): 2679-84
43. Hunold P, Schmermund A, Seibel RM, et al. Prevalence and clinical significance of accidental findings in electron-beam tomographic scans for coronary artery calcification. Eur Heart J 2001 Sep; 22 (18): 1748-58
44. Keelan PC, Bielak LF, Ashai K, et al. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 2001 Jul 24; 104 (4): 412-7
45. Obuchowski NA, Modic MT, Magdinec M, et al. Assessment of the efficacy of noninvasive screening for patients with asymptomatic neck bruits. Stroke 1997 Jul; 28 (7): 1330-9
46. Botnar RM, Stuber M, Kissinger KV, et al. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000 Nov 21; 102 (21): 2582-7
47. Ruehm SG, Goyen M, Barkhausen J, et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 2001 Apr 7; 357 (9262): 1086-91
48. Meaney JF, Ridgway JP, Chakraverty S, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 1999 Apr; 211 (1): 59-67
49. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994 Apr; 191 (1): 155-64
50. Hoch JR, Tullis MJ, Kennell TW, et al. Use of magnetic resonance angiography for the preoperative evaluation of patients with infrainguinal arterial occlusive disease. J Vasc Surg 1996 May; 23 (5): 792-801
51. Carpenter JP, Baum RA, Holland GA, et al. Peripheral vascular surgery with magnetic resonance angiography as the sole preoperative imaging modality. J Vasc Surg 1994 Dec; 20 (6): 861-71
52. Winterer JT, Schaefer O, Uhrmeister P, et al. Contrast enhanced MR angiography in the assessment of relevant stenoses in occlusive disease of the pelvic and lower limb arteries: diagnostic value of a two-step examination protocol in comparison to conventional DSA. Eur J Radiol 2002 Feb; 41 (2): 153-60
53. Holmqvist C, Stahlberg F, Hanseus K, et al. Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels. J Magn Reson Imaging 2002 Jan; 15 (1): 39-46
54. Bogaert J, Kuzo R, Dymarkowski S, et al. Follow-up of patients with previous treatment for coarctation of the thoracic aorta: comparison between contrast-enhanced MR angiography and fast spin-echo MR imaging. Eur Radiol 2000; 10 (12): 1847-54
55. Chung T. Assessment of cardiovascular anatomy in patients with congenital heart disease by magnetic resonance imaging. Pediatr Cardiol 2000 Jan-Feb; 21 (1): 18-26
56. Amundsen T, Kvaerness J, Jones RA, et al. Pulmonary embolism: detection with MR perfusion imaging of lung - a feasibility study. Radiology 1997 Apr; 203 (1): 181-5
57. Moody AR, Liddicoat A, Krarup K. Magnetic resonance pulmonary angiography and direct imaging of embolus for the detection of pulmonary emboli. Invest Radiol 1997 Aug; 32 (8): 431-40
58. Berthezene Y, Croisille P, Wiart M, et al. Prospective comparison of MR lung perfusion and lung scintigraphy. J Magn Reson Imaging 1999 Jan; 9 (1): 61-8
59. Mai VM, Bankier AA, Prasad PV, et al. MR ventilation-perfusion imaging of human lung using oxygen-enhanced and arterial spin labeling techniques. J Magn Reson Imaging 2001 Nov; 14 (5): 574-9
60. Nakagawa T, Sakuma H, Murashima S, et al. Pulmonary ventilation-perfusion MR imaging in clinical patients. J Magn Reson Imaging 2001 Oct; 14 (4): 419-24
61. Bremerich J, Roberts TP, Wendland MF, et al. Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan). J Magn Reson Imaging 2000 Jun; 11 (6): 622-8
62. Abolmaali ND, Hietschold V, Appold S, et al. Gadomer-17-enhanced 3D navigator-echo MR angiography of the pulmonary arteries in pigs. Eur Radiol 2002 Mar; 12 (3): 692-7
63. Zheng J, Carr J, Harris K, et al. Three-dimensional MR pulmonary perfusion imaging and angiography with an injection of a new blood pool contrast agent B-22956/1. J Magn Reson Imaging 2001 Oct; 14 (4): 425-32
64. Mistretta CA, Grist TM. X-ray digital subtraction angiography to magnetic resonance-digital subtraction angiography using three-dimensional TRICKS. Historical perspective and computer simulations: a review. Invest Radiol 1998 Sep; 3(9): 496-505
65. Yu X, Song SK, Chen J, et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000 Dec; 44 (6): 867-72
66. Huber ME, Oelhafen ME, Kozerke S, et al. Single breath-hold extended free-breathing navigator-gated three-dimensional coronary MRA. J Magn Reson Imaging 2002 Feb; 15 (2): 210-4
67. Stuber M, Botnar RM, Danias PG, et al. Breathhold three-dimensional coronary magnetic resonance angiography using real-time navigator technology. J Cardiovasc Magn Reson 1999; 1 (3): 233-8
68. Taylor AM, Keegan J, Jhooti P, et al. Calculation of a subject-specific adaptive motion-correction factor for improved real-time navigator echo-gated magnetic resonance coronary angiography. J Cardiovasc Magn Reson 1999; 1 (2): 131-8
69. Nikolaou K, Huber A, Knez A, Scheidler J, Petsch R, Reiser M. Navigator echo-based respiratory gating for three-dimensional MR coronary angiography: reduction of scan time using a slice interpolation technique. J Comput Assist Tomogr 2001 May-Jun; 25 (3): 378-387
70. Molinari G, Sardanelli F, Zandrino F, et al. Value of navigator echo magnetic resonance angiography in detecting occlusion/patency of arterial and venous, single and sequential coronary bypass grafts. Int J Card Imaging 2000 Jun; 16 (3): 149-60
71. Ho VB, Foo TK, Arai AE, et al. Gadolinium-enhanced, vessel-tracking, two-dimensional coronary MR angiography: single-dose arterial-phase vs. delayed-phase imaging. J Magn Reson Imaging 2001 May; 13 (5): 682-9
72. Sandstede JJ, Pabst T, Wacker C, et al. Breath-hold 3D MR coronary angiography with a new intravascular contrast agent (feruglose) - first clinical experiences. Magn Reson Imaging 2001 Feb; 19 (2): 201-5
73. Klein C, Nagel E, Schnackenburg B, et al. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease. MAGMA 2000 Nov; 11 (1-2): 65-7
74. Li D, Zheng J, Weinmann HJ. Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology 2001 Mar; 218 (3): 670-8
75. Rose SC, Zwiebel WJ, Nelson BD, et al. Symptomatic lower extremity deep venous thrombosis: accuracy, limitations, and role of color duplex flow imaging in diagnosis. Radiology 1990 Jun; 175 (3): 639-44
76. Ruehm SG, Wiesner W, Debatin JF. Pelvic and lower extremity veins: contrast-enhanced three-dimensional MR venography with a dedicated vascular coil-initial experience. Radiology 2000 May; 215 (2): 421-7
77. Boeve WJ, Kok T, Haagsma EB, et al. Superior diagnostic strength of combined contrast enhanced MR-angiography and MR-imaging compared to intra-arterial DSA in liver transplantation candidates. Magn Reson Imaging 2001 Jun; 19 (5): 609-22
78. Schalla S, Nagel E, Lehmkuhl H, et al. Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol 2001 Jan 1; 87 (1): 95-9
79. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999 Feb 16; 99 (6): 763-70
80. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999 Nov 9; 100 (19): 1992-2002
81. Kim RJ, Hillenbrand HB, Judd RM. Evaluation of myocardial viability by MRI. Herz 2000 Jun; 25 (4): 417-30
82. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997 Aug; 204 (2): 373-84
83. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000 Mar 28; 101 (12): 1379-83
84. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001 May 8; 103 (18): 2230-5
85. Kraitchman DL, Chin BB, Heldman AW, et al. MRI detection of myocardial perfusion defects due to coronary artery stenosis with MS-325. J Magn Reson Imaging 2002 Feb; 15 (2): 149-58
86. Arheden H, Saeed M. Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echoplanar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999 Jun; 211 (3): 698-708
87. Arheden H, Saeed M, Higgins CB, et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology May 2000; 215 (2):520-8
88. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000 Nov 15; 36 (6): 1985-91
89. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002 Jan 15; 105 (2): 162-7
90. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000 Nov 16; 343 (20): 1445-53
91. Oshinski JN, Yang Z, Jones JR, et al. Imaging time after GdDTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001 Dec 4; 104 (23): 2838-42
92. Saeed M, Lund G, Wendland MF, et al. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 2001 Feb 13; 103 (6): 871-6
93. Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985 Jun 27; 312 (26): 1665-71
94. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989 Jan; 117 (1): 211-21
95. Horie H, Takahashi M, Minai K, et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation 1998 Dec 1; 98 (22): 2377-82
96. Diesbourg LD, Prato FS, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992 Feb; 23 (2): 239-53
97. Saeed M, Higgins CB, Geschwind JF, et al. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging. Eur Radiol 2000; 10 (2): 310-8
98. Wendland MF, Saeed M, Lund G, et al. Contrast-enhanced MRI for quantification of myocardial viability. J Magn Reson Imaging 1999 Nov; 10 (5): 694-702
99. Dymarkowski S, Ni Y, Miao Y, et al. Value of T2-Weighted Magnetic Resonance Imaging Early After Myocardial Infarction in Dogs: Comparison With Bis-Gadolinium-Mesoporphyrin Enhanced T1-Weighted Magnetic Resonance Imaging and Functional Data From Cine Magnetic Resonance Imaging. Invest Radiol 2002 Feb; 37 (2): 77-85
100. Ni Y, Pislaru C, Bosmans H, et al. Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging. Eur Radiol 2001; 11 (5): 876-83
101. Jeong AK, Choi SI, Kim DH, et al. Evaluation by contrast-enhanced MR imaging of the lateral border zone in reperfused myocardial infarction in a cat model. Korean J Radiol 2001 Jan-Mar; 2 (1): 21-27
102. Brurok H, Skoglund T, Berg K, et al. Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts. NMR Biomed 1999 Oct; 12 (6): 364-72
103. De Roos A, van Rossum AC, van der Wall E, et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA - enhanced MR imaging. Radiology 1989 Sep; 172 (3): 717-20
104. De Roos A, Matheijssen NA, Doornbos J, et al. Myocardial infarct size after reperfusion therapy: assessment with Gd-DTPA-enhanced MR imaging. Radiology 1990 Aug; 176 (2): 517-21
105. Van Rossum AC, Visser FC, Van Eenige MJ, et al. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol 1990 Apr 1; 65 (13): 845-51
106. Pearlman JD, Laham RJ, Simons M. Coronary angiogenesis: detection in vivo with MR imaging sensitive to collateral neocirculation - preliminary study in pigs. Radiology 2000 Mar; 214 (3): 801-7
107. Lauerma K, Saeed M, Wendland MF, et al. Verapamil reduces the size of reperfused ischemically injured myocardium in hypertrophied rat hearts as assessed by magnetic resonance imaging. Am Heart J 1996 Jan; 131 (1): 14-23
108. Watzinger N, Saeed M, Wendland MF, et al. Myocardial viability: magnetic resonance assessment of functional reserve and tissue characterization. J Cardiovasc Magn Reson 2001; 3 (3): 195-208
109. Serfaty JM, Yang X, Aksit P, et al. Toward MRI-guided coronary catheterization: visualization of guiding catheters, guidewires, and anatomy in real time. J Magn Reson Imaging 2000 Oct; 12 (4): 590-4
110. Moats R, Fraser S, Meade T. A smart magnetic resonance imaging agent that reports on specific enzymatic activity. Angew Chem Int Ed Engl 1997; 36: 726-8
111. Pomper M. Molecular imaging: An overview. Acad Radiol 2001; 8: 1141-53
112. Spuentrup E, Ruebben A, Schaeffter T, et al. Magnetic resonance--guided coronary artery stent placement in a swine model. Circulation 2002 Feb 19; 105 (7): 874-9
113. Kuehne T, Saeed M, Moore P, et al. Influence of blood-pool contrast media on MR imaging and flow measurements in the presence of pulmonary arterial stents in swine. Radiology 2002 May;223 (2): 439-45
114. Folkman J. Angiogenic therapy of the human heart. Circulation 1998 Feb 24; 97 (7): 628-9
115. Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996 Sep 1; 94 (5): 1074-82
116. Tanaka E, Hattan N, Ando K, et al. Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits. J Thorac Cardiovasc Surg 2000 Oct; 120 (4): 720-8
117. Laham RJ, Chronos NA, Pike M, et al. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. J Am Coll Cardiol 2000 Dec; 36 (7): 2132-9
118. Laham RJ, Sellke FW, Edelman ER, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999 Nov 2; 100 (18): 1865-71
119. Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999 Aug 3; 100 (5): 468-74
120. Vale PR, Losordo DW, Milliken CE, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001 May 1; 103 (17): 2138-43
121. Henry TD, Rocha-Singh K, Isner JM, et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 2001 Nov; 142 (5): 872-80
122. Lederman RJ, Guttman MA, Peters DC, et al. Catheter-based endomyocardial injection with real-time magnetic resonance imaging. Circulation 2002 Mar 19; 105 (11): 1282-4